Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 25 (7%) | |
| Anticipated shortage: | 6 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
6 (19%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VALSARTAN | 320MG | TABLET | Resolved | 2018-07-10 | 2018-12-29 | 55161 |
| VALSARTAN | 320MG | TABLET | Resolved | 2018-07-10 | 2021-08-17 | 55164 |
| VALSARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2020-01-16 | 2020-02-24 | 103427 |
| TERBINAFINE | 250MG | TABLET | Resolved | 2018-06-26 | 2018-09-20 | 52990 |
| TERBINAFINE | 250MG | TABLET | Resolved | 2018-06-26 | 2018-09-20 | 52993 |
| TERBINAFINE | 250MG | TABLET | Resolved | 2019-08-05 | 2020-09-04 | 90687 |
| TERBINAFINE | 250MG | TABLET | Resolved | 2019-08-05 | 2020-09-04 | 90690 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66689 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70366 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-01 | 2019-07-06 | 80246 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126591 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2023-11-22 | 2024-04-01 | 211146 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66692 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70369 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2019-05-06 | 2019-05-31 | 83165 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126594 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66695 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-01 | 2019-05-31 | 80249 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-11 | 2020-07-02 | 108484 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-17 | 2020-07-02 | 108850 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53291 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53294 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53297 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53300 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53303 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53306 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53327 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-10-22 | 53330 |
| ALENDRONATE | 70MG | TABLET | Discontinued | 2018-06-29 | 2018-07-31 | 53369 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2018-06-29 | 2018-07-31 | 53374 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2018-06-29 | 2018-07-31 | 53377 |
| ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53380 |
| ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53383 |
| ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53386 |
| ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53389 |
| ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53393 |
| ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53398 |